The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Aberrant rel/nfkb genes and activity in human cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Structure, Regulation and Function of NF-kappaB
Siebenlist, U., Franzoso, G., & Brown, K. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,075
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,825
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
How NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Chu, Z.-L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., & Ballard, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10057 · Cited by 872
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Köntgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., & Gerondakis, S. (1995) · Genes & Development · doi:10.1101/gad.9.16.1965 · Cited by 727
Wang, W., Abbruzzese, J. L., Evans, D. B., Larry, L., Cleary, K. R., & Chiao, P. J. (1999) · PubMed · Cited by 726
Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator
Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H., & Nabel, G. J. (1997) · Science · doi:10.1126/science.275.5299.523 · Cited by 722
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Zong, W.-X., Edelstein, L. C., Chen, C., Bash, J., & Gelinas, C. (1999) · Genes & Development · doi:10.1101/gad.13.4.382 · Cited by 720
Wang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 590
Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras
Mayo, M. W., Wang, C.-Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., & Baldwin, A. S. (1997) · Science · doi:10.1126/science.278.5344.1812 · Cited by 533
Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J., & Cheng, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9136 · Cited by 521
Beg, A. A., Sha, W. C., Bronson, R. T., & Baltimore, D. (1995) · Genes & Development · doi:10.1101/gad.9.22.2736 · Cited by 473
Ohno, H. (1990) · Cell · doi:10.1016/0092-8674(90)90347-h · Cited by 456
Krikos, A., Laherty, C. D., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37138-8 · Cited by 444
Seitz, C. S., Lin, Q., Deng, H., & Khavari, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2307 · Cited by 436
Franzoso, G., Carlson, L., Poljak, L., Shores, E. W., Epstein, S., Leonardi, A., Grinberg, A., Tran, T., Scharton-Kersten, T., Anver, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.147 · Cited by 425
IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival
Wu, M. X., Ao, Z., Prasad, K. V. S., Wu, R., & Schlossman, S. F. (1998) · Science · doi:10.1126/science.281.5379.998 · Cited by 413
Grumont, R. J., Rourke, I. J., & Gerondakis, S. (1999) · Genes & Development · doi:10.1101/gad.13.4.400 · Cited by 403
Caamaño, J. H., Rizzo, C. A., Durham, S. K., Barton, D. S., Raventós-Suárez, C., Snapper, C. M., & Bravo, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.185 · Cited by 395
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
Neri, A., Chang, C.-C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A. T., Chaganti, R. S. K., & Dalla-Favera, R. (1991) · Cell · doi:10.1016/0092-8674(91)90285-7 · Cited by 390
Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., & Baldwin, A. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24113 · Cited by 375
Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis.
Grimm, S., Bauer, M. K., Baeuerle, P. A., & Schulze-Osthoff, K. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.1.13 · Cited by 354
IκBα Deficiency Results in a Sustained NF-κB Response and Severe Widespread Dermatitis in Mice
Klement, J. F., Rice, N. R., Car, B. D., Abbondanzo, S. J., Powers, G. D., Bhatt, H., Chen, C.-H., Rosen, C. A., & Stewart, C. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2341 · Cited by 340
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F., & Hay, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202893 · Cited by 334
Chromosomal and Gene Amplification in Diffuse Large B-Cell Lymphoma
Rao, P. H., Houldsworth, J., Dyomina, K., Parsa, N. Z., Cigudosa, J. C., Louie, D. C., Popplewell, L., Offit, K., Jhanwar, S. C., & Chaganti, R. S. K. (1998) · Blood · doi:10.1182/blood.v92.1.234.413k22_234_240 · Cited by 331
Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T., & Grumont, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203236 · Cited by 329
The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators
Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F. G., Scheidereit, C., & Leutz, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202717 · Cited by 312
High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
Bargou, R., Leng, C., Krappmann, D., Emmerich, F., Mapara, M., Bommert, K., Royer, H., Scheidereit, C., & Dorken, B. (1996) · Blood · doi:10.1182/blood.v87.10.4340.bloodjournal87104340 · Cited by 309
Regulation of DNA binding by Rel/NF-κB transcription factors: structural views
Chen, F. E., & Ghosh, G. (1999) · Oncogene · doi:10.1038/sj.onc.1203224 · Cited by 301
bcl-2 and Other Genomic Alterations in the Prognosis of Large-Cell Lymphoma
Yunis, J. J., Mayer, M. G., Arnesen, M. A., Aeppli, D. P., Oken, M. M., & Frizzera, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904203201605 · Cited by 292
La Rosa, F. A., Pierce, J. W., & Sonenshein, G. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1039 · Cited by 283
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
Duyao, M. P., Buckler, A. J., & Sonenshein, G. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4727 · Cited by 278
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dörken, B., & Scheidereit, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202351 · Cited by 271
Bours, V, Burd, P. R., Brown, K., Villalobos, J., Park, S., Ryseck, R. P., Bravo, R., Kelly, K., & Siebenlist, U. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.685 · Cited by 269
Higgins, K. A., Perez, J. R., Coleman, T. A., Dorshkind, K., McComas, W. A., Sarmiento, U. M., Rosen, C. A., & Narayanan, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9901 · Cited by 261
Abbadie, C., Kabrun, N., Bouali, F., Smardova, J., Stéhelin, D., Vandenbunder, B., & Enrietto, P. J. (1993) · Cell · doi:10.1016/0092-8674(93)90534-w · Cited by 228
Lai, J., Zandecki, M., Mary, J., Bernardi, F., Izydorczyk, V, Flactif, M., Morel, P., Jouet, J., Bauters, F., & Facon, T. (1995) · Blood · doi:10.1182/blood.v85.9.2490.bloodjournal8592490 · Cited by 216
Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-κB
Kitajima, I., Shinohara, T., Bilakovics, J., Brown, D. A., Xu, X., & Nerenberg, M. (1992) · Science · doi:10.1126/science.1299224 · Cited by 212
REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma
Houldsworth, J., Mathew, S., Rao, P., Dyomina, K., Louie, D., Parsa, N., Offit, K., & Chaganti, R. (1996) · Blood · doi:10.1182/blood.v87.1.25.25 · Cited by 211
Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway
Epinat, J.-C., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203218 · Cited by 211
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells
Zhou, G., & Kuo, M. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15174 · Cited by 193
Sun, S.-C., & Ballard, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1203220 · Cited by 185
Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M.-P., & Castronovo, V. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90448-0 · Cited by 185
Franzoso, G., Carlson, L., Scharton-Kersten, T., Shores, E. W., Epstein, S., Grinberg, A., Tran, T., Shacter, E., Leonardi, A., Anver, M., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80291-5 · Cited by 177
Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R.-P., & Bravo, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.999 · Cited by 176
You, M., Ku, P.-T., Hrdličková, R., & Bose, H. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7328 · Cited by 176
Visconti, R., Cerutti, J., Battista, S., Fedele, M., Trapasso, F., Zeki, K., Miano, M. P., de Nigris, F., Casalino, L., Curcio, F., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201373 · Cited by 168
Motokura, T., & Arnold, A. (1993) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870070205 · Cited by 163
McFarland, E. D. C., Izumi, K. M., & Mosialos, G. (1999) · Oncogene · doi:10.1038/sj.onc.1203217 · Cited by 159
Schmitz, M. L., Stelzer, G., Altmann, H., Meisterernst, M., & Baeuerle, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7219 · Cited by 158
c-Rel is essential for B lymphocyte survival and cell cycle progression
Tumang, J. R., Owyang, A. M., Andjelić, S., Jin, Z., Hardy, R. R., Liou, M.-L., & Liou, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199812)28:12<4299::aid-immu4299>3.0.co;2-y · Cited by 128
Defective IκBα in Hodgkin cell lines with constitutively active NF-κB
Wood, K. M., Roff, M. A., & Hay, R. T. (1998) · Oncogene · doi:10.1038/sj.onc.1201735 · Cited by 127
Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
Dejardin, E., Deregowski, V., Chapelier, M., Jacobs, N., GIELEN, J. E., Merville, M., & Bours, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202599 · Cited by 125
Sumitomo, M., Tachibana, M., Nakashima, J., Murai, M., Miyajima, A., Kimura, F., Hayakawa, M., & Nakamura, H. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61993-1 · Cited by 120
Bash, J., Zong, W., & Gélinas, C. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6526 · Cited by 117
Self-citationCaamaño, J., Pérez, P., Lira, S. A., & Bravo, R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1342 · Cited by 106
Migliazza, A., Lombardi, L. T., Rocchi, M., Trecca, D., Chang, C. M., Antonacci, R., Fracchiolla, N., Ciana, P., Maiolo, A. T., & Neri, A. (1994) · Blood · doi:10.1182/blood.v84.11.3850.bloodjournal84113850 · Cited by 104
Bcl-2 Suppresses Apoptosis Resulting from Disruption of the NF-κB Survival Pathway☆
HERRMANN, J., Beham, A. W., Sarkiss, M. G., Chiao, P. J., Rands, M. G., Bruckheimer, E., Brisbay, S. M., & McDonnell, T. J. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3737 · Cited by 104
Xu, X. D., Prorock, C. M., Ishikawa, H., Maldonado, E., Ito, Y., & Gélinas, C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.6733-6741.1993 · Cited by 102
Self-citationA new characteristic karyotypic anomaly in lymphoproliferative disorders
BERGHE, H. V. D., Parloir, C., David, G., Michaux, J., & SOKAL, G. (1979) · Cancer · doi:10.1002/1097-0142(197907)44:1<188::aid-cncr2820440131>3.0.co;2-f · Cited by 94
Bentires‐Alj, M., Hellin, A., Ameyar‐Zazoua, M., Chouaïb, S., Merville, M. P., & Bours, V. (1999) · PubMed · Cited by 94
Khaled, Z., Benimetskaya, L., Zeltser, R., Khan, T., Sharma, H. W., Narayanan, R., & Stein, C. A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.4.737 · Cited by 90
Alterations in NF B Activation in T Lymphocytes of Patients With Renal Cell Carcinoma
Uzzo, R. G., Clark, P., Rayman, P. A., Bloom, T., Rybicki, L. A., Novick, A. C., Bukowski, R. M., & Finke, J. H. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.8.718 · Cited by 88
Devalaraja, M. N., Wang, D. Z., Ballard, D. W., & Richmond, A. J. (1999) · PubMed · Cited by 87
INK4 cell cycle inhibitors direct transcriptional inactivation of NF-κB
Wolff, B., & Naumann, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202617 · Cited by 85
The v‐rel oncogene promotes malignant T‐cell leukemia/lymphoma in transgenic mice.
Carrasco, D. R., Rizzo, C. A., Dorfman, K. S., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00733.x · Cited by 76
t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: A review of 23 cases
Michaux, L., Dierlamm, J., Wlodarska, I., Bours, V., den Berghe, H. V., & Hagemeijer, A. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00247-6 · Cited by 75
Sumitomo, M., Tachibana, M., Murai, M., Hayakawa, M., Nakamura, H., Shimizu, N., Ozu, C., Asakura, H., & Takayanagi, A. (1999) · Human Gene Therapy · doi:10.1089/10430349950019174 · Cited by 70
Newton, T. R., Patel, N. M., Bhat‐Nakshatri, P., Stauss, C. R., Goulet, R. J., & Nakshatri, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18827 · Cited by 64
Carrasco, D. R., Cheng, J. D., Lewin, A. C., Warr, G. A., Yang, H., Rizzo, C. A., Rosas, F., Snapper, C. M., & Bravo, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.973 · Cited by 62
Ling, W., Rayman, P. A., Uzzo, R. G., Clark, P. E., Kim, H. J., Tubbs, R., Novick, A. C., Bukowski, R. M., Hamilton, T. A., & Finke, J. H. (1998) · Blood · doi:10.1182/blood.v92.4.1334 · Cited by 61
Overexpression of RelA Causes G1 Arrest and Apoptosis in a Pro-B Cell Line
Sheehy, A. M., & Schlissel, M. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8708 · Cited by 51
Ciana, P., Neri, A., Cappellini, C., Cavallo, F., Pomati, M., Chang, C., Maiolo, A. T., & Lombardi, L. (1997) · Oncogene · doi:10.1038/sj.onc.1201015 · Cited by 40
Physical interaction of the bHLH LYL1 protein and NF-κB1 p105
Ferrier, R., Nougarède, R., Doucet, S., Kahn‐Perlès, B., Imbert, J., & Mathieu-Mahul, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202374 · Cited by 40
Chen, C., Agnès, F., & Gélinas, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.307 · Cited by 26
Self-citationPerletti, L., Talarico, D., Trecca, D., Ronchetti, D., Fracchiolla, N., Maiolo, A. T., & Neri, A. (1997) · Genomics · doi:10.1006/geno.1997.5022 · Cited by 26
v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFα-induced cell death
Zong, W., Farrell, M., Bash, J., & Gélinas, C. (1997) · Oncogene · doi:10.1038/sj.onc.1201266 · Cited by 23
Self-citationMaxwell, S. A., & Mukhopadhyay, T. (1995) · Gene · doi:10.1016/0378-1119(95)00578-1 · Cited by 13
Cited by
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Metadata
- Authors
- Rayet, B., & Gélinas, C.
- Venue
- Oncogene
- Published
- 1999-11-22
- Volume
- 18
- Issue
- 49
- Pages
- 6938-6947
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2027260180
- Cited by
- 1,110
- References
- 93
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.